Developer docs
API playgroundTry for free, no card

Search company profiles

Intellegens

Full company profile

uuid00025x5

Namestring
Intellegens
Legal namestring
Intellegens Limited
Websiteurl
intellegens.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Intellegens Limited is a Cambridge, UK-based private company founded in 2017 that commercializes Alchemite™, a proprietary deep learning platform originating from research at the University of Cambridge. Alchemite is purpose-built to build predictive models from sparse, noisy, and incomplete experimental and process data — the characteristic data profile of industrial R&D in chemicals, materials, formulations, manufacturing, and life sciences — and to support adaptive Design of Experiments, formulation optimization, explainable R&D analytics, and emerging agentic workflows. The platform is delivered through a browser-based Analytics interface and an Architect edition with API access, with vertical modules for DOE, Formulations, R&D Insights, and Oligonucleotide Manufacturing.

The company operates a hybrid go-to-market combining product-led free trials and demo requests with enterprise field sales targeting large industrial customers. Revenue is generated through quote-based annual SaaS subscriptions of the Alchemite Suite and a parallel professional services stream branded Alchemite Success, which includes pilot project support, training via Alchemite Academy, and custom implementation. Pricing is not publicly disclosed. Customer segments span chemicals, materials, life sciences (including oligonucleotide therapeutics), FMCG and foods, and additive manufacturing, with named logos including NASA, Boeing, Rolls-Royce, Johnson Matthey, Genentech, Novartis, Voestalpine, FUCHS, Tata Steel, Godrej Aerospace, Lawrence Livermore National Laboratory, and AMRC. Marketing is delivered through technical content (case studies, white papers, publications), webinars, industry conferences, the Alchemite Focus Group community, and the academic programme.

Intellegens is bootstrapped — its disclosed funding consists entirely of Innovate UK grants, most notably a £1.6 million award in August 2023 for oligonucleotide therapeutics manufacturing — with no disclosed venture capital or private equity investment. The company holds ISO 27001 certification, employs 11-50 staff, and was recognised with ASME AM Tech Forum Best in Class Software and Startup awards in 2021 and selection for the ATI Boeing Accelerator in 2019.

Short descriptiontext

Intellegens commercializes Alchemite™, a proprietary Cambridge-developed deep learning platform that builds predictive models from sparse, noisy R&D data, serving enterprise customers in chemicals, materials, life sciences, manufacturing, and FMCG through SaaS subscriptions and professional services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
machine learning software, R&D analytics platform, design of experiments, formulation optimization, materials informatics
Industry3 codes
PRIMARYHDAEANAB
Model Development & Training Platforms (AutoML, Notebooks, Feature Stores)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYBPAEAAAJ
AI/ML Solution Integration & MLOps Enablement
SECONDARYEDAGAKAC
Corporate Learning & Training Content Development
Education/Educational Publishing & Learning Content/Instructional Design & Content Development Services
NAICS code4 codes
  • Software Publishers5132
  • Computer Systems Design and Related Services54151
  • Scientific Research and Development Services5417
  • Computer Training611420
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Machine Learning Software for R&D
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software Licensing (Alchemite Suite)
TypeSubscription Recurring
Description

SaaS subscription-based licensing of the Alchemite machine learning software platform. Customers access the software through a web-based interface with tiered options for different team sizes and use cases. The model includes free trials for evaluation and professional services for onboarding.

intellegens.com
2Professional Services
TypeProfessional Services
Description

Consulting and technical support services including Alchemite Success team engagement, pilot project support, training (Alchemite Academy), and custom implementation assistance to help organizations maximize value from the platform.

intellegens.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise subscription with custom pricing based on organization size and deployment scope
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing; annual subscription model; includes software access, support, and training

intellegens.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1Alchemite™ Suite
Description

AI-powered machine learning software platform for design of experiments, formulations, and R&D insights

intellegens.com
+5 more records
Core offering1 text field

Intellegens develops and licenses the Alchemite™ Suite, an enterprise machine learning software platform that builds predictive models from sparse, noisy, and incomplete experimental data for R&D teams in chemicals, materials, FMCG, life sciences, and manufacturing. The platform includes specialized modules for Design of Experiments, formulations, R&D insights, and oligonucleotide manufacturing, delivered as an annual subscription with quote-based pricing plus optional professional services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 50-80% reduction in experimental workload
+5 more records
Product overview1 text field

Intellegens offers the Alchemite™ Suite as its core product platform, a unified machine learning solution designed for R&D teams in chemicals, materials, FMCG, life sciences, and manufacturing. The platform employs unique deep learning technology developed at the University of Cambridge that works with sparse, noisy experimental data where conventional machine learning fails. The product architecture includes the Alchemite™ Analytics browser-based platform for scientists and engineers, the Alchemite™ Architect edition with API access for data scientists, and specialized modules including Alchemite™ for DOE (Design of Experiments), Alchemite™ for Formulations, Alchemite™ for R&D Insights, and Alchemite™ for Oligonucleotide Manufacturing. Supporting offerings include the Alchemite™ Academic Programme, Alchemite™ Academy for training, and Alchemite™ Success Services for consultancy support. Intellegens also offers the Ichnite™ software product for data management. The platform enables adaptive experimental design that reduces experimental workloads by 50-80% while finding solutions missed by traditional DOE methods.

Product and service10 records
1Alchemite™ Suite
CategoryMachine Learning Software Platform
Description

Unified machine learning platform applying deep learning for sparse, noisy data to optimize products and processes across chemicals, materials, FMCG, life sciences, and manufacturing sectors.

2Alchemite™ for DOE
CategoryMachine Learning Software Module
Description

Design of Experiments module that cuts 50-80% from experimental workloads while finding solutions that traditional DOE methods would miss, enabling faster, fewer, better experiments for R&D teams.

3Alchemite™ for Formulations
CategoryMachine Learning Software Module
Description

Formulation development module for chemicals, materials, and consumer products that accelerates innovation by rapidly optimizing formulations, materials, and chemicals.

4Alchemite™ for R&D Insights
CategoryMachine Learning Software Module
Description

Analytics and insights module that unlocks hidden value in experimental and process data, empowering data-driven decision making through explainable AI tools.

5Alchemite™ for Oligonucleotide Manufacturing
CategoryMachine Learning Software Module
Description

Specialized module applying AI and machine learning to accelerate process development for oligonucleotide therapeutics manufacturing, improving productivity and quality control.

6Alchemite™ Analytics
CategoryMachine Learning Software Platform
Description

Browser-based web user interface platform for scientists and engineers to apply Alchemite through tailored workflows for formulation, materials, chemical, and process design.

7Alchemite™ Architect
CategoryMachine Learning Software Platform
Description

Platform edition providing API access for data scientists to integrate the Alchemite algorithm with their own scripts and tools for integration with existing workflows.

8Alchemite™ Success Services
CategoryProfessional Services
Description

Consultancy and support services to help customers successfully apply Alchemite to their R&D challenges, including project guidance and domain expertise.

9Alchemite™ Academic Programme
CategorySoftware Access Program
Description

Program providing academic researchers access to Alchemite machine learning software for research and educational purposes.

10Alchemite™ Academy
CategoryTraining Services
Description

Training initiative that upskills researchers in machine learning applications for R&D, providing educational resources alongside the software platform.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-30
Description

Collaboration on Innovate UK-funded £1.6 million project to enhance manufacturing of oligonucleotide therapeutics using machine learning. CPI provides medicines manufacturing expertise and validation capabilities for Alchemite in biopharmaceutical applications.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-30
Description

Industry partner in the Innovate UK oligonucleotide therapeutics project. Novartis contributes pharmaceutical manufacturing expertise and real-world data for machine learning model development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-30
Description

Specialized oligonucleotide therapeutics company collaborating on the Innovate UK project to improve manufacturing productivity for these complex biologic drugs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing collaboration on automotive catalyst design using machine learning. Published peer-reviewed paper on accelerating catalyst product design with Alchemite. Multiple joint publications and ongoing projects.

5NASA
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NASA Glenn Research Center collaboration to validate Alchemite for materials design. Published NASA Technical Memorandum applying Alchemite to shape memory alloys and heat exchangers. Joint webinar and ongoing technical collaboration.

intellegens.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Project MEDAL collaboration with AMRC, Constellium, and GE Additive for data-driven additive manufacturing. Boeing contributes aerospace manufacturing expertise and validates Alchemite for AM process optimization.

7AMRC (University of Sheffield)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Advanced Manufacturing Research Centre collaboration on additive manufacturing and composite tooling optimization. AMRC applies Alchemite to aerospace and automotive manufacturing challenges.

intellegens.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Project MEDAL partner for data-driven additive manufacturing. Constellium provides aluminum expertise and validates Alchemite for aerospace materials development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Project MEDAL partner applying machine learning to additive manufacturing process optimization with GE Additive's metal AM systems.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Early collaboration on nickel-base superalloy design using neural networks. Alchemite designed alloys satisfying 11 physical criteria, validated experimentally.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Build UK-India programme partner supporting cleantech collaboration between UK and Indian industry. Intellegens provides machine learning technology for net zero manufacturing projects.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Build UK-India project partner working with Intellegens, Godrej Aerospace, and Johnson Matthey to reduce energy and resource consumption in manufacturing processes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Build UK-India project partner applying machine learning to aerospace manufacturing to reduce waste and improve sustainability.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to drive materials innovation, combining Intellegens machine learning with Royce's materials research capabilities and network.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on additive manufacturing application of Alchemite machine learning for materials and component design.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Origin of Alchemite technology; ongoing research collaboration with Cambridge researchers including CSO Dr Gareth Conduit. Joint publications on concrete design and noise exploitation algorithms.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership to empower additive manufacturing with material intelligence through machine learning. Ansys Granta and Intellegens combined expertise to improve battery metrics with AI.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Engineering simulation and analytics platform with materials informatics and design optimization capabilities. Competes indirectly through broader CAE and AI-driven design tooling for industrial customers.

TypeEmerging player
Description

Provider of digital twin technology augmented by AI for industrial process optimization. Comparable where AI is used to optimize complex industrial processes in chemicals and manufacturing.

TypeEmerging player
Description

Early-stage AI-for-materials company applying machine learning to accelerate discovery of new chemicals and materials. Operates in the same AI-R&D niche as Intellegens but at smaller scale.

TypeDirect peer
Description

Computational chemistry and materials simulation platform widely used in drug discovery and materials R&D. Overlaps with Intellegens where predictive modeling drives experimental prioritization for chemistry and formulations customers.

TypeDirect peer
Description

AI platform purpose-built for materials and chemicals R&D, offering data infrastructure and ML models for formulation and process optimization. Closest direct competitor in the AI-for-materials niche that Intellegens targets.

TypeBroad incumbent
Description

Enterprise scientific informatics suite spanning lab informatics, materials modeling, and formulation. Competes for the same enterprise budgets as Intellegens but as a broader portfolio offering rather than a specialist ML tool.

TypeBroad incumbent
Description

Simulation giant with growing AI/ML capabilities for materials, additive manufacturing, and battery design. Already a partner but also a competitor as Ansys Granta integrates data-driven material intelligence features.

TypeDirect peer
Description

Provider of simulation and modeling tools for materials science, including atomistic and mesoscale methods. Recently announced a partnership with Intellegens, indicating direct overlap in materials R&D tooling.

TypeDirect peer
Description

Scientific R&D platform offering ELN, data management, and analytics for chemistry and life sciences labs. Comparable in serving enterprise R&D users integrating ML insights into lab workflows.

TypeDirect peer
Description

Drug discovery software provider focused on small molecule design and ADMET prediction. Comparable in pharmaceutical R&D use cases and is already a named partner of Intellegens in cheminformatics work.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers22 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Intellegens

Machine Learning Software for R&Dintellegens.com

Intellegens commercializes Alchemite™, a proprietary Cambridge-developed deep learning platform that builds predictive models from sparse, noisy R&D data, serving enterprise customers in chemicals, materials, life sciences, manufacturing, and FMCG through SaaS subscriptions and professional services.

What Intellegens does

Intellegens Limited is a Cambridge, UK-based private company founded in 2017 that commercializes Alchemite™, a proprietary deep learning platform originating from research at the University of Cambridge. Alchemite is purpose-built to build predictive models from sparse, noisy, and incomplete experimental and process data — the characteristic data profile of industrial R&D in chemicals, materials, formulations, manufacturing, and life sciences — and to support adaptive Design of Experiments, formulation optimization, explainable R&D analytics, and emerging agentic workflows. The platform is delivered through a browser-based Analytics interface and an Architect edition with API access, with vertical modules for DOE, Formulations, R&D Insights, and Oligonucleotide Manufacturing.

The company operates a hybrid go-to-market combining product-led free trials and demo requests with enterprise field sales targeting large industrial customers. Revenue is generated through quote-based annual SaaS subscriptions of the Alchemite Suite and a parallel professional services stream branded Alchemite Success, which includes pilot project support, training via Alchemite Academy, and custom implementation. Pricing is not publicly disclosed. Customer segments span chemicals, materials, life sciences (including oligonucleotide therapeutics), FMCG and foods, and additive manufacturing, with named logos including NASA, Boeing, Rolls-Royce, Johnson Matthey, Genentech, Novartis, Voestalpine, FUCHS, Tata Steel, Godrej Aerospace, Lawrence Livermore National Laboratory, and AMRC. Marketing is delivered through technical content (case studies, white papers, publications), webinars, industry conferences, the Alchemite Focus Group community, and the academic programme.

Intellegens is bootstrapped — its disclosed funding consists entirely of Innovate UK grants, most notably a £1.6 million award in August 2023 for oligonucleotide therapeutics manufacturing — with no disclosed venture capital or private equity investment. The company holds ISO 27001 certification, employs 11-50 staff, and was recognised with ASME AM Tech Forum Best in Class Software and Startup awards in 2021 and selection for the ATI Boeing Accelerator in 2019.

Intellegens firmographics

Firmographics
Name
Intellegens
Legal name
Intellegens Limited
Website
https://intellegens.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Intellegens commercializes Alchemite™, a proprietary Cambridge-developed deep learning platform that builds predictive models from sparse, noisy R&D data, serving enterprise customers in chemicals, materials, life sciences, manufacturing, and FMCG through SaaS subscriptions and professional services.
Ownership category
akta.pro rank

Intellegens industry classification

Industry
Product category
Machine Learning Software for R&D
NAICS
Software Publishers (5132), Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417), Computer Training (611420)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHDAEANAB
Model Development & Training Platforms (AutoML, Notebooks, Feature Stores)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYBPAEAAAJ
AI/ML Solution Integration & MLOps Enablement
SECONDARYEDAGAKAC
Corporate Learning & Training Content Development
Education/Educational Publishing & Learning Content/Instructional Design & Content Development Services

Keywords

  • Machine learning software
  • R&D analytics platform
  • Design of experiments
  • Formulation optimization
  • Materials informatics

Where Intellegens is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Intellegens business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Licensing (Alchemite Suite): SaaS subscription-based licensing of the Alchemite machine learning software platform. Customers access the software through a web-based interface with tiered options for different team sizes and use cases. The model includes free trials for evaluation and professional services for onboarding.
  2. Professional Services: Consulting and technical support services including Alchemite Success team engagement, pilot project support, training (Alchemite Academy), and custom implementation assistance to help organizations maximize value from the platform.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription with custom pricing based on organization size and deployment scope

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Intellegens product offering

Product offering

Core offering

Intellegens develops and licenses the Alchemite™ Suite, an enterprise machine learning software platform that builds predictive models from sparse, noisy, and incomplete experimental data for R&D teams in chemicals, materials, FMCG, life sciences, and manufacturing. The platform includes specialized modules for Design of Experiments, formulations, R&D insights, and oligonucleotide manufacturing, delivered as an annual subscription with quote-based pricing plus optional professional services.

Product overview

Intellegens offers the Alchemite™ Suite as its core product platform, a unified machine learning solution designed for R&D teams in chemicals, materials, FMCG, life sciences, and manufacturing. The platform employs unique deep learning technology developed at the University of Cambridge that works with sparse, noisy experimental data where conventional machine learning fails. The product architecture includes the Alchemite™ Analytics browser-based platform for scientists and engineers, the Alchemite™ Architect edition with API access for data scientists, and specialized modules including Alchemite™ for DOE (Design of Experiments), Alchemite™ for Formulations, Alchemite™ for R&D Insights, and Alchemite™ for Oligonucleotide Manufacturing. Supporting offerings include the Alchemite™ Academic Programme, Alchemite™ Academy for training, and Alchemite™ Success Services for consultancy support. Intellegens also offers the Ichnite™ software product for data management. The platform enables adaptive experimental design that reduces experimental workloads by 50-80% while finding solutions missed by traditional DOE methods.

Differentiator

Problem solved

Functional benefit

Brands

  • Alchemite™ Suite: AI-powered machine learning software platform for design of experiments, formulations, and R&D insights
  • Alchemite™ for DOE
  • Alchemite™ for Formulations
  • Alchemite™ for R&D Insights
  • Alchemite™ for Oligonucleotides
  • Ichnite™

Products and services

  • Alchemite™ Suite Unified machine learning platform applying deep learning for sparse, noisy data to optimize products and processes across chemicals, materials, FMCG, life sciences, and manufacturing sectors.
  • Alchemite™ for DOE Design of Experiments module that cuts 50-80% from experimental workloads while finding solutions that traditional DOE methods would miss, enabling faster, fewer, better experiments for R&D teams.
  • Alchemite™ for Formulations Formulation development module for chemicals, materials, and consumer products that accelerates innovation by rapidly optimizing formulations, materials, and chemicals.
  • Alchemite™ for R&D Insights Analytics and insights module that unlocks hidden value in experimental and process data, empowering data-driven decision making through explainable AI tools.
  • Alchemite™ for Oligonucleotide Manufacturing Specialized module applying AI and machine learning to accelerate process development for oligonucleotide therapeutics manufacturing, improving productivity and quality control.
  • Alchemite™ Analytics Browser-based web user interface platform for scientists and engineers to apply Alchemite through tailored workflows for formulation, materials, chemical, and process design.
  • Alchemite™ Architect Platform edition providing API access for data scientists to integrate the Alchemite algorithm with their own scripts and tools for integration with existing workflows.
  • Alchemite™ Success Services Consultancy and support services to help customers successfully apply Alchemite to their R&D challenges, including project guidance and domain expertise.
  • Alchemite™ Academic Programme Program providing academic researchers access to Alchemite machine learning software for research and educational purposes.
  • Alchemite™ Academy Training initiative that upskills researchers in machine learning applications for R&D, providing educational resources alongside the software platform.

Quantifiable outcome

  • 50-80% reduction in experimental workload
  • +5 more outcomes

Companies that use Intellegens

Customer profile

Named customers22 records

Segments6 records

Ideal customer profiles5 records

Intellegens technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature9 records

Intellegens partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core.

  • CPI (Centre for Process Innovation)coreStrategic or Co-development Partner · 30 August 2023Collaboration on Innovate UK-funded £1.6 million project to enhance manufacturing of oligonucleotide therapeutics using machine learning. CPI provides medicines manufacturing expertise and validation capabilities for Alchemite in biopharmaceutical applications.
  • NovartiscoreStrategic or Co-development Partner · 30 August 2023Industry partner in the Innovate UK oligonucleotide therapeutics project. Novartis contributes pharmaceutical manufacturing expertise and real-world data for machine learning model development.
  • Silence TherapeuticscoreStrategic or Co-development Partner · 30 August 2023Specialized oligonucleotide therapeutics company collaborating on the Innovate UK project to improve manufacturing productivity for these complex biologic drugs.
  • Johnson MattheycoreStrategic or Co-development PartnerLong-standing collaboration on automotive catalyst design using machine learning. Published peer-reviewed paper on accelerating catalyst product design with Alchemite. Multiple joint publications and ongoing projects.
  • NASAcoreStrategic or Co-development PartnerNASA Glenn Research Center collaboration to validate Alchemite for materials design. Published NASA Technical Memorandum applying Alchemite to shape memory alloys and heat exchangers. Joint webinar and ongoing technical collaboration.
  • BoeingcoreStrategic or Co-development PartnerProject MEDAL collaboration with AMRC, Constellium, and GE Additive for data-driven additive manufacturing. Boeing contributes aerospace manufacturing expertise and validates Alchemite for AM process optimization.
  • AMRC (University of Sheffield)coreStrategic or Co-development PartnerAdvanced Manufacturing Research Centre collaboration on additive manufacturing and composite tooling optimization. AMRC applies Alchemite to aerospace and automotive manufacturing challenges.
  • ConstelliumcoreStrategic or Co-development PartnerProject MEDAL partner for data-driven additive manufacturing. Constellium provides aluminum expertise and validates Alchemite for aerospace materials development.
  • GE AdditivecoreStrategic or Co-development PartnerProject MEDAL partner applying machine learning to additive manufacturing process optimization with GE Additive's metal AM systems.
  • Rolls-RoycecoreStrategic or Co-development PartnerEarly collaboration on nickel-base superalloy design using neural networks. Alchemite designed alloys satisfying 11 physical criteria, validated experimentally.
  • Digital CatapultcoreStrategic or Co-development PartnerBuild UK-India programme partner supporting cleantech collaboration between UK and Indian industry. Intellegens provides machine learning technology for net zero manufacturing projects.
  • Tata SteelcoreStrategic or Co-development PartnerBuild UK-India project partner working with Intellegens, Godrej Aerospace, and Johnson Matthey to reduce energy and resource consumption in manufacturing processes.
  • Godrej AerospacecoreStrategic or Co-development PartnerBuild UK-India project partner applying machine learning to aerospace manufacturing to reduce waste and improve sustainability.
  • Henry Royce InstitutecoreStrategic or Co-development PartnerPartnership to drive materials innovation, combining Intellegens machine learning with Royce's materials research capabilities and network.
  • Lawrence Livermore National LaboratorycoreStrategic or Co-development PartnerCollaboration on additive manufacturing application of Alchemite machine learning for materials and component design.
  • University of CambridgecoreStrategic or Co-development PartnerOrigin of Alchemite technology; ongoing research collaboration with Cambridge researchers including CSO Dr Gareth Conduit. Joint publications on concrete design and noise exploitation algorithms.
  • AnsyscoreTechnology or IntegrationPartnership to empower additive manufacturing with material intelligence through machine learning. Ansys Granta and Intellegens combined expertise to improve battery metrics with AI.

Scale indicators6 records

Recent moves3 records

Expansion highlights6 records

Intellegens competitors and assessment

Company assessment

Broad incumbents

  • Altair Engineering: Engineering simulation and analytics platform with materials informatics and design optimization capabilities. Competes indirectly through broader CAE and AI-driven design tooling for industrial customers.
  • Dassault Systèmes BIOVIA: Enterprise scientific informatics suite spanning lab informatics, materials modeling, and formulation. Competes for the same enterprise budgets as Intellegens but as a broader portfolio offering rather than a specialist ML tool.
  • Ansys: Simulation giant with growing AI/ML capabilities for materials, additive manufacturing, and battery design. Already a partner but also a competitor as Ansys Granta integrates data-driven material intelligence features.

Emerging players

  • Cosmo Tech: Provider of digital twin technology augmented by AI for industrial process optimization. Comparable where AI is used to optimize complex industrial processes in chemicals and manufacturing.
  • Kebotix: Early-stage AI-for-materials company applying machine learning to accelerate discovery of new chemicals and materials. Operates in the same AI-R&D niche as Intellegens but at smaller scale.

Direct peers

  • Schrödinger: Computational chemistry and materials simulation platform widely used in drug discovery and materials R&D. Overlaps with Intellegens where predictive modeling drives experimental prioritization for chemistry and formulations customers.
  • Citrine Informatics: AI platform purpose-built for materials and chemicals R&D, offering data infrastructure and ML models for formulation and process optimization. Closest direct competitor in the AI-for-materials niche that Intellegens targets.
  • Materials Design, Inc. Provider of simulation and modeling tools for materials science, including atomistic and mesoscale methods. Recently announced a partnership with Intellegens, indicating direct overlap in materials R&D tooling.
  • Dotmatics: Scientific R&D platform offering ELN, data management, and analytics for chemistry and life sciences labs. Comparable in serving enterprise R&D users integrating ML insights into lab workflows.
  • Optibrium: Drug discovery software provider focused on small molecule design and ADMET prediction. Comparable in pharmaceutical R&D use cases and is already a named partner of Intellegens in cheminformatics work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Intellegens social profiles

Digital presence

Intellegens compliance and trust

Trust signal

Compliance1 record

Intellegens financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Intellegens leadership team

Management profile

Number of profiles

Profiles7 records

Intellegens funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Intellegens M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intellegens

What does Intellegens do?

Intellegens develops and licenses the Alchemite™ Suite, an enterprise machine learning software platform that builds predictive models from sparse, noisy, and incomplete experimental data for R&D teams in chemicals, materials, FMCG, life sciences, and manufacturing. The platform includes specialized modules for Design of Experiments, formulations, R&D insights, and oligonucleotide manufacturing, delivered as an annual subscription with quote-based pricing plus optional professional services.

Is Intellegens a public or private company?

Intellegens is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Intellegens founded?

Intellegens was founded in 2017. It employs 11 to 50 people.

Where is Intellegens based?

Intellegens is headquartered in Cambridge, United Kingdom, in the Europe region.

How does Intellegens make money?

Two revenue lines are on record. Software Licensing (Alchemite Suite) is the primary driver. The others are professional Services.

Who are Intellegens's main competitors?

Broad incumbents on record are Altair Engineering, Dassault Systèmes BIOVIA and Ansys. Emerging players are Cosmo Tech and Kebotix. Direct peers are Schrödinger, Citrine Informatics, Materials Design, Inc., Dotmatics and Optibrium.

Does Intellegens have an API?

Yes. Alchemite™ Architect edition provides API access to integrate the Alchemite™ algorithm with users' own scripts and tools. Data scientists can use this to integrate the machine learning capabilities with their existing workflows.

What industry is Intellegens in?

Intellegens's product category is Machine Learning Software for R&D. Its primary akta.pro industry code is HDAEANAB, Model Development & Training Platforms (AutoML, Notebooks, Feature Stores), with a secondary code of BPAEAAAJ, AI/ML Solution Integration & MLOps Enablement. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PRLogIntellegens and Materials Design, Inc. Collaborate to Accelerate Materials ResearchIntellegens and Materials Design, Inc. are collaborating to combine Alchemite machine learning with MedeA simulation software for materials research. The partnership was validated in a project modeling polymer biodegradability, which used fewer computational resources than either technology alone. The collaboration targets sectors including advanced materials, chemicals, electronics, and energy.Pulse 2.0Intellegens: Interview With CEO Ben Pellegrini About The Process Solutions CompanyIntellegens CEO Ben Pellegrini discussed the company's machine learning platform for R&D, including the Alchemite Suite launched in January 2025. The company cites customer success stories from Johnson Matthey, NASA, and others, and plans new products using large language models and federated learning.BusinessCloud£1.6m grant to target range of diseases through machine learningIntellegens secured a £1.6 million Innovate UK grant to apply machine learning to oligonucleotide therapeutic manufacturing. The two-year project, with the Centre for Process Innovation, aims to improve productivity and yields using its Alchemite tool. Expert support from six research organisations, including Novartis and Silence Therapeutics, will be provided.Tech Funding NewsIntellegens gets £1.6M grant to advance manufacture of oligonucleotide therapeutics with machine learning — TFNIntellegens has secured a £1.6 million grant from Innovate UK to apply its machine learning technology, Alchemite, to improve the manufacturing of oligonucleotide therapeutics. The two-year project is conducted in collaboration with the Centre for Process Innovation (CPI) and supported by research organizations including Novartis and Silence Therapeutics. This initiative aims to enhance productivity and yields in the complex production process of these next-generation drugs.UK Manufacturing OnlineProject to help drive adoption of machine learning wins funding from Innovate UKIntellegens has secured funding from Innovate UK KTN to lead a consortium aimed at accelerating the adoption of machine learning in the UK materials and chemicals industries. The project, which began on May 1st, will analyze barriers to AI implementation and develop 'Explainable AI' tools to enhance trust and compliance among participants including Johnson Matthey and Domino Printing Sciences. This initiative is part of a broader £21m investment by Innovate UK to promote responsible AI technologies across UK industry.NatureMassive data initiatives and AI provide testbed for pandemic forecastingUK studies OpenSAFELY and COVID-19 Symptom Study used big data to identify risk factors and symptoms for COVID-19, including ethnicity and loss of taste. AI initiatives like Zoe and Intellegens aim to improve forecasting, though data quality remains a challenge. Hybrid approaches combining machine learning and mechanistic models are emerging.outsourcing-pharma.com‘The opportunities for AI to revolutionize the pharmaceutical industry are clear’: ReportA PreScouter report highlights AI's potential to revolutionize drug discovery, citing long timelines, high costs, and low success rates. It notes AI is past proof-of-concept, with Optibrium-Intellegens partnership and a NUS study using CURATE.AI to optimize cancer dosing. The NUS team expects broader deployment and reduced drug development costs.BusinessCloud£1m innovation boost for drug discovery platformInnovate UK announced £1 million funding for a project where Optibrium, Intellegens, and Medicines Discovery Catapult will use AI to improve drug discovery. The two-year collaboration aims to guide compound design and testing, addressing high failure rates where nine out of ten drugs fail before approval.Energy Systems CatapultDeep learning drug discovery platform gets £1M boostOptibrium, Intellegens, and Medicines Discovery Catapult secured a £1 million Innovate UK grant to develop a deep learning platform for drug discovery. The project aims to predict ADMET properties of new drug candidates, addressing high failure rates where 9 out of 10 drugs fail between phase 1 and approval.